Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The aim of this work was to compare the glucose-lowering efficacy of dipeptidyl peptidase-4
(DPP-4) inhibitors between Asian and non-Asian patients with type 2 diabetes.